Skip to Content

Xifaxan Salix Pharmaceuticals, Ltd - Treatment for Travelers’ Diarrhea

Xifaxan is a nonsystemic gastrointestinal-selective, oral antibiotic indicated for the treatment of patients (12 years of age and older) with traveler's diarrhea caused by noninvasive strains of Escherichia coli.

Posted: May 2004

Related Articles:

Xifaxan (rifaximin) FDA Approval History

More News Resources

Subscribe to our Newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of in your inbox.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.